Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm to identify and triage patients suspected of suffering from HCM.
The companies are offering healthcare organizations a holistic program that goes beyond the traditional break-fix approach to medical device maintenance.
The Endurant abdominal aortic aneurysm stent graft system continues to demonstrate long-term durability through proven outcomes in a real-world setting.
The insulin delivery device was designed to serve the more than 3M people using basal insulin or transitioning to insulin therapy to treat their type 2 diabetes